Literature DB >> 12609761

Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling.

Aljosa Bavec1, Mattias Hällbrink, Ulo Langel, Matjaz Zorko.   

Abstract

Previous studies revealed the importance of the third intracellular loop of glucagon-like peptide-1 receptor (GLP-1R) in coupling to G(s) and G(i1) proteins. In order to further study the signaling mechanisms of GLP-1R, we tested three peptides, corresponding to the sequences of the first (IC(1)), the second (IC(2)), and the third (IC(3)) intracellular loop of GLP-1R, for their interactions with heterotrimeric G-proteins of different types (G(alphas), G(alphao), G(alphai1), and G(alpha11) plus G(beta1gamma2)) overexpressed in sf9 cells. IC(3) peptide powerfully stimulates all types of tested G-proteins, whereas IC(1) and IC(2) peptides show differential effects on G-proteins. Both IC(1) and IC(2) peptides activate G(s) and cooperate with IC(3) peptide in its stimulation. G(o) is not affected by IC(1) and IC(2). G(i1) and G(11) are not affected by IC(1), but are activated by IC(2), which in activation cooperates with IC(3). We suggest that GLP-1R is not coupled only to G(s) and G(i1), as shown previously, but also to G(o) and G(11). IC(3) loop is the main switch that mediates signaling via GLP-1R to G-proteins, while IC(1) and IC(2) loops are important in discrimination between different types of G-proteins. Copyright 2002 Elsevier Science B.V.

Mesh:

Substances:

Year:  2003        PMID: 12609761     DOI: 10.1016/s0167-0115(02)00282-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  15 in total

1.  Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.

Authors:  Karen Coopman; Yan Huang; Neil Johnston; Sophie J Bradley; Graeme F Wilkinson; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2010-05-27       Impact factor: 4.030

2.  Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.

Authors:  Mojca Jensterle; Boštjan Pirš; Katja Goričar; Vita Dolžan; Andrej Janež
Journal:  Eur J Clin Pharmacol       Date:  2015-05-21       Impact factor: 2.953

Review 3.  A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion.

Authors:  Makoto Shigeto; Chae Young Cha; Patrik Rorsman; Kohei Kaku
Journal:  J Mol Med (Berl)       Date:  2017-01-17       Impact factor: 4.599

4.  Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

Authors:  K Coopman; R Wallis; G Robb; A J H Brown; G F Wilkinson; D Timms; G B Willars
Journal:  Mol Endocrinol       Date:  2011-08-25

5.  Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy.

Authors:  Siva Bhashyam; Anjali V Fields; Brandy Patterson; Jeffrey M Testani; Li Chen; You-Tang Shen; Richard P Shannon
Journal:  Circ Heart Fail       Date:  2010-05-13       Impact factor: 8.790

6.  Glucagon like-peptide-1 receptor is covalently modified by endogenous mono-ADP-ribosyltransferase.

Authors:  Matjaž Deželak; Aljoša Bavec
Journal:  Mol Biol Rep       Date:  2011-09-08       Impact factor: 2.316

7.  Role of cysteine 341 and arginine 348 of GLP-1 receptor in G-protein coupling.

Authors:  Aljosa Bavec; Yang Jiang; Ulo Langel; Matjaz Zorko
Journal:  Mol Biol Rep       Date:  2006-11-14       Impact factor: 2.316

8.  Functional characterization of N-terminally GFP-tagged GLP-1 receptor.

Authors:  Aljosa Bavec; Alenka Licar
Journal:  J Biomed Biotechnol       Date:  2009-10-22

9.  GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation.

Authors:  Makoto Shigeto; Reshma Ramracheya; Andrei I Tarasov; Chae Young Cha; Margarita V Chibalina; Benoit Hastoy; Koenraad Philippaert; Thomas Reinbothe; Nils Rorsman; Albert Salehi; William R Sones; Elisa Vergari; Cathryn Weston; Julia Gorelik; Masashi Katsura; Viacheslav O Nikolaev; Rudi Vennekens; Manuela Zaccolo; Antony Galione; Paul R V Johnson; Kohei Kaku; Graham Ladds; Patrik Rorsman
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.

Authors:  Naichang Li; Jing Lu; Gary B Willars
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.